# Cannabinoids for Behavioral Problems in Children With ASD

> **NCT02956226** · PHASE2 · COMPLETED · sponsor: **Shaare Zedek Medical Center** · enrollment: 150 (actual)

## Conditions studied

- Autistic Disorder

## Interventions

- **DRUG:** Cannabinoids - 99% pure cannabinoids mix
- **DRUG:** Placebo
- **DRUG:** Cannabinoids - whole plant extract

## Key facts

- **NCT ID:** NCT02956226
- **Lead sponsor:** Shaare Zedek Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2018-10
- **Final completion:** 2018-12
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2018-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02956226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02956226, "Cannabinoids for Behavioral Problems in Children With ASD". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02956226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*